1261 Patterns of dermatological and other immune related adverse events as a signal for survival

1261 Patterns of dermatological and other immune related adverse events as a signal for survival

Bibliographic Details
Main Authors:	Eric Olson, Andrew Faucheux, John Hunting, Ruth Sacks, Tom Lycan
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

The Recapture of Constantinople in 1261: An Accident or a Pattern?
by: Nikolay Barabanov, et al.
Published: (2023-12-01)

Characteristics of rapid cycling in 1261 bipolar disorder patients
by: Alessandro Miola, et al.
Published: (2023-06-01)

MECHANISM OF POWER CHANGE IN THE EARLY-BAHRITE PERIOD (1250-1261)
by: Filippov Alexander
Published: (2016-01-01)

A Review of Bullous Dermatologic Adverse Events Associated with Anti-Cancer Therapy
by: Rose Parisi, et al.
Published: (2023-01-01)

v.41, n.7, p.1255-1261, jul, 2011
Published: (2011-09-01)

“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management
by: Pietro Sollena, et al.
Published: (2022-05-01)

[Translated article] Adverse Dermatologic Reactions in Patients Treated With Immune Checkpoint Inhibitors
by: R. Fayos Gregori, et al.
Published: (2023-03-01)

Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
by: Laura C Cappelli, et al.
Published: (2024-04-01)

Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma
by: Josep Corominas, et al.
Published: (2021-01-01)

Copper-induced adaptation, oxidative stress and its tolerance in Aspergillus niger UCP1261
by: Marcos A. Cavalcanti Luna, et al.
Published: (2015-11-01)

Timeline of Adverse Events during Immune Checkpoint Inhibitors for Advanced Melanoma and Their Impacts on Survival
by: Lorena Villa-Crespo, et al.
Published: (2022-02-01)

Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study
by: Pietro Sollena, et al.
Published: (2023-07-01)

Dermatological adverse effects of COVID-19 vaccines
by: Elçin Akdaş, et al.
Published: (2022-12-01)

Clinical Patterns and Follow-Up of Inflammatory Arthritis and Other Immune-Related Adverse Events Induced by Checkpoint Inhibitors. A Multicenter Study
by: José A. Gómez-Puerta, et al.
Published: (2022-06-01)

Dermatologic adverse events associated with epidermal growth factor receptor inhibitors: current concepts of interdisciplinary problem
by: A. S. Polonskaia, et al.
Published: (2022-02-01)

Cerebriform patterns in dermatology
by: Anup Kumar Tiwary
Published: (2021-08-01)

Pituitary-Related Adverse Events and Onset Patterns Caused by Immune Checkpoint Inhibitors: Analysis Using the Japanese Adverse Drug Event Report Database
by: Hiroki Asano, et al.
Published: (2023-11-01)

Serious dermatological adverse effects of vortioxetine: two cases
by: Mesut Cetin, et al.
Published: (2018-07-01)

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region
by: Milan J. Anadkat, et al.
Published: (2023-01-01)

Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
by: Heidar J. Albandar, et al.
Published: (2021-02-01)

LAW 1.261/2015: obstacles to implement new public policies for tourism in São Paulo-Brazil
by: Cíntia Möller Araujo
Published: (2017-01-01)

Las constituciones de don Raimundo de Lozaña para el cabildo de Sevilla (1261)
by: Enrique Costa y Belda
Published: (1978-12-01)

Unexpected Adverse Events of Immune Checkpoint Inhibitors
by: Walid Shalata, et al.
Published: (2023-07-01)

Immune-Related Adverse Events of the Gastrointestinal System
by: Steven Nicolaides, et al.
Published: (2023-01-01)

Mucocutaneous adverse events to immune checkpoint inhibitors
by: Fiorinda Muhaj, et al.
Published: (2023-03-01)

Ocular adverse events with immune checkpoint inhibitors
by: Tony Fang, et al.
Published: (2019-09-01)

Pan-immune-inflammation and its dynamics: predictors of survival and immune-related adverse events in patients with advanced NSCLC receiving immunotherapy
by: Yiqun Chen, et al.
Published: (2023-10-01)

Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events
by: Mehmet Altan, et al.
Published: (2023-12-01)

Dermatologic adverse effect of subcutaneous furosemide administration in a cat
by: Chiara Mazzoldi, et al.
Published: (2023-08-01)

Clinical-Genomic Analysis of 1261 Patients with Ehlers–Danlos Syndrome Outlines an Articulo-Autonomic Gene Network (Entome)
by: Golder N. Wilson, et al.
Published: (2024-03-01)

العلاقات الدبلوماسية بين المماليك والامبراطورية البيزنطية (660ه-815ه /1261م-/1412م)
by: غادة حسن
Published: (2020-06-01)

العلاقات الدبلوماسية بين المماليك والامبراطورية البيزنطية (660ه-815ه /1261م-/1412م)
by: Ghada Hassan
Published: (2020-06-01)

خطط مدینة الموصل خلال العصور الاسلامیة (16 -660هـ/ 637-1261 م ) (رسالة ماجستیر)
by: فیان محمد, et al.
Published: (2003-06-01)

G. de Moor, Verborgen en geborgen. Het cisterziënzerinnenklooster Leeuwenhorst in de Noordwijkse regio (1261-1574)
by: P. Trio
Published: (1997-01-01)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
by: Aoi Noda, et al.
Published: (2020-07-01)

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes
by: Charline Lafayolle de la Bruyère, et al.
Published: (2021-05-01)

Patterns of immune-related adverse events in patients treated with immune checkpoint inhibitors: a Brazilian real-world analysis
by: Maria Paula Furtado Santos, et al.
Published: (2022-12-01)

Impact of Immune-Related Adverse Events on Immune Checkpoint Inhibitors Treated Cancer Patients’ Survival: Single Center Experience and Literature Review
by: Raquel Romão, et al.
Published: (2023-01-01)

Cutaneous immune-related adverse events among Taiwanese cancer patients receiving immune checkpoint inhibitors link to a survival benefit
by: Yung-Tsu Cho, et al.
Published: (2022-04-01)

Immune checkpoint inhibitors associated cardiovascular immune-related adverse events
by: Wonyoung Jo, et al.
Published: (2024-02-01)